Ensysce Biosciences, Inc. (ENSC)
NASDAQ: ENSC · Real-Time Price · USD
0.5512
+0.0867 (18.67%)
At close: Apr 13, 2026, 4:00 PM EDT
0.4998
-0.0514 (-9.33%)
After-hours: Apr 13, 2026, 6:17 PM EDT
Ensysce Biosciences Stock Forecast
Stock Price Forecast
There have not been any analyst price target forecasts for Ensysce Biosciences in the last 12 months.
Price Target: n/a
Analyst Consensus: n/a
Analyst Ratings
There are currently no analyst ratings available for Ensysce Biosciences.
Recommendation Trends
| Rating | May '23 | Jun '23 | Jul '23 | Aug '23 | Sep '23 |
|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 2 | 2 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 2 | 2 | 0 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $135 → $105 | Strong Buy | Maintains | $135 → $105 | +18,949.35% | Sep 25, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $135 | Strong Buy | Initiates | $135 | +24,392.02% | Jul 3, 2023 |
| Lake Street | Lake Street | Strong Buy Maintains $14,400 → $1,440 | Strong Buy | Maintains | $14,400 → $1,440 | +261,148.19% | Nov 17, 2022 |
| Lake Street | Lake Street | Strong Buy Initiates $14,400 | Strong Buy | Initiates | $14,400 | +2,612,381.86% | Nov 30, 2021 |
Financial Forecast
Revenue This Year
n/a
from 5.07M
Revenue Next Year
89.06M
EPS This Year
-3.61
from -3.98
EPS Next Year
n/a
from -3.61
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 |
|---|---|---|
| High | n/a | 91.7M |
| Avg | n/a | 89.1M |
| Low | n/a | 85.6M |
Revenue Growth
| Revenue Growth | 2026 | 2027 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
EPS Forecast
| EPS | 2026 |
|---|---|
| High | -3.72 |
| Avg | -3.61 |
| Low | -3.47 |
EPS Growth
| EPS Growth | 2026 |
|---|---|
| High | - |
| Avg | - |
| Low | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.